You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

Drugs in ATC Class A01A


✉ Email this page to a colleague

« Back to Dashboard


Subclasses in ATC: A01A - STOMATOLOGICAL PREPARATIONS

A01A Market Analysis and Financial Projection

The ATC Class A01A (Stomatological Preparations) encompasses treatments for oral conditions, including caries prevention, gingivitis, and stomatitis. This category includes fluoride-based products like sodium fluoride[6][15], which are critical for dental mineralization and caries management. Below is an analysis of its market dynamics and patent landscape:


Market Dynamics

Growth Drivers

  • Rising Dental Disease Burden: Over 514 million children and 2 billion adults globally suffer from untreated dental caries, driving demand for preventive solutions like fluoride treatments[3].
  • Technological Advancements: Adoption of digital dentistry and 3D printing in prosthetics and orthodontics enhances product efficacy[4][9].
  • Aging Populations: Increased prevalence of age-related oral diseases (e.g., periodontal disease) fuels demand for specialized stomatological products[3][13].

Market Size and Projections

  • The global dental protein combined products market (closely aligned with A01A) reached $1.02 billion in 2024, projected to grow at 10% CAGR through 2030[3].
  • In Belgium/Luxembourg, A01A ranked third in unit growth (+53,221 units) and seventh in value growth (€6.5 million) as of 2018[1].

Key Players

  • Institut Straumann AG, Dentsply Sirona, and 3M lead innovation in dental care products[3][11].
  • Sodium fluoride formulations dominate caries prevention, with combinations like olaflur-dectaflur gaining traction[6][15].

Regional Trends

  • North America: Holds 40.7% market share due to high dental health awareness and aging demographics[3].
  • Asia-Pacific: Emerging as a growth hub, driven by China’s focus on 3D-printed dental solutions and patent filings[4][11].

Patent Landscape

Innovation Focus Areas

  • 3D Printing Technologies: Over 50% of recent patents target prosthetics and orthodontic devices, with SLA and DLP methods leading[4][11].
  • Bioactive Materials: Antimicrobial coatings and smart implants with embedded sensors for real-time monitoring are key R&D priorities[11][14].
  • Digital Workflows: Patents for AI-driven treatment planning and automated caries detection systems rose 33% since 2018[14].

Key Patent Jurisdictions

  • United States: Leads with 60,000+ dental patents, emphasizing AI and material science[11][14].
  • China: Accounts for 35% of 3D printing patents in stomatology, focusing on cost-effective solutions[4].
  • South Korea: Specializes in minimally invasive dental adhesives and bioactive coatings[4][11].

Challenges

  • Ethical Concerns: Gene-editing patents (e.g., CRISPR) face scrutiny over accessibility and licensing[14].
  • Fragmented Standards: Disparities in international patent enforcement complicate cross-border collaborations[14].

"The application of 3D printing technology in stomatology is emerging and has great potential, but patent quality needs improvement to match global standards." [4]

This analysis highlights A01A’s alignment with broader trends in preventive dental care and advanced manufacturing, positioning it for sustained growth amid evolving regulatory and technological landscapes.

References

  1. https://www.iqvia.com/-/media/iqvia/pdfs/belgium/sales-trends/2018/belgian-reg-med-best-performers-for-october-2018.pdf?la=sk-sk&hash=5F03C3AA6255CA928A6446DA47F98DC6
  2. https://www.wipo.int/ipc/itos4ipc/ITSupport_and_download_area/20160101/pdf/scheme/full_ipc/en/ipc_en_a_full_ipc_20160101.pdf
  3. https://www.grandviewresearch.com/industry-analysis/dental-protein-combined-products-market-report
  4. http://manu45.magtech.com.cn/Jwk_kqyxyj/EN/abstract/abstract2182.shtml
  5. https://www.frontiersin.org/journals/research-metrics-and-analytics/articles/10.3389/frma.2023.978249/full
  6. https://go.drugbank.com/drugs/DB09325
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC10286779/
  8. https://www.wipo.int/edocs/pubdocs/en/wipo_pub_949_1.pdf
  9. https://www.lek.com/sites/default/files/PDFs/us-dental-outlook.pdf
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC6617087/
  11. https://www.expertmarketresearch.com/patent-analysis/dental-implants-patent-landscape
  12. https://alphaarchitect.com/2021/04/market-timing-using-aggregate-equity-allocation-signals/
  13. https://www.marketresearchfuture.com/reports/dental-industry-market/market-trends
  14. https://ip.com/blog/2025-patent-trends-challenges-and-innovations-shaping-the-future-of-technology/
  15. https://atcddd.fhi.no/atc_ddd_index/?code=A01A&showdescription=yes
  16. https://farmaciajournal.com/wp-content/uploads/art-25-Pana_Craciun-Taerel_813-820.pdf

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.